Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Features associated with epilepsy in the antiphospholipid syndrome.
Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P, Lev N, Zaech J, Cervera R, Piette JC, Khamashta MA, Bertolaccini ML, Hughes GR, Youinou P, Meroni PL, Pengo V, Alves JD, Tincani A, Szegedi G, Lakos G, Sturfelt G, Jönsen A, Koike T, Sanmarco M, Ruffatti A, Ulcova-Gallova Z, Praprotnik S, Rozman B, Lorber M, Chapman J, van-Breda-Vriezman PJ, Damoiseaux J. Shoenfeld Y, et al. Among authors: pengo v. J Rheumatol. 2004 Jul;31(7):1344-8. J Rheumatol. 2004. PMID: 15229954
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository.
Gkrouzman E, Sevim E, Finik J, Andrade D, Pengo V, Sciascia S, Tektonidou MG, Ugarte A, Chighizola CB, Belmont HM, Lopez-Pedrera C, Ji L, Fortin P, Efthymiou M, de Jesus GR, Branch DW, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Cohen H, Rand J, Erkan D; APS ACTION+. Gkrouzman E, et al. Among authors: pengo v. J Rheumatol. 2021 Apr;48(4):541-547. doi: 10.3899/jrheum.200513. Epub 2020 Sep 1. J Rheumatol. 2021. PMID: 33259328 Free PMC article.
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry.
Aiello A, Sarti L, Sandri G, Poli D, Sivera P, Barcellona D, Prisco D, Pizzini AM, Vercillo G, Antonucci E, Palareti G, Pengo V; Start2 Antiphospholipid Registry collaborators. Aiello A, et al. Among authors: pengo v. Int J Lab Hematol. 2024 Dec 11. doi: 10.1111/ijlh.14416. Online ahead of print. Int J Lab Hematol. 2024. PMID: 39660556
An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Devreese KMJ, Bertolaccini ML, Branch DW, de Laat B, Erkan D, Favaloro EJ, Pengo V, Ortel TL, Wahl D, Cohen H. Devreese KMJ, et al. Among authors: pengo v. J Thromb Haemost. 2024 Nov 5:S1538-7836(24)00638-X. doi: 10.1016/j.jtha.2024.10.022. Online ahead of print. J Thromb Haemost. 2024. PMID: 39510414
Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study.
Palareti G, Legnani C, Testa S, Paoletti O, Cini M, Antonucci E, Pengo V, Poli D, Ageno W, Prandoni P, Prisco D, Tosetto A; MAS Working Group. Palareti G, et al. Among authors: pengo v. Curr Probl Cardiol. 2025 Jan;50(1):102913. doi: 10.1016/j.cpcardiol.2024.102913. Epub 2024 Oct 30. Curr Probl Cardiol. 2025. PMID: 39481583
461 results